Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man.
| Autor: | McKillop, D.1 david.mckillop@astrazeneca.com, Hutchison, M.1, Partridge, E. A.1, Bushby, N.1, Cooper, C. M. F.1, Clarkson-Jones, J. A.1, Herron, W.2, Swaisland, H. C.1 |
|---|---|
| Zdroj: | Xenobiotica. Oct2004, Vol. 34 Issue 10, p917-934. 18p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|